CDXS vs REGN: Which Stock is Better?
Side-by-side comparison of Codexis Inc and Regeneron Pharmaceuticals Inc in 2026
CDXS
Codexis Inc
—
REGN
Regeneron Pharmaceuticals Inc
$678.94
Key Metrics Comparison
| Metric | CDXS | REGN | Winner |
|---|---|---|---|
| Market Cap | $257.65M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CDXS
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CDXS or REGN a better investment?
Comparing CDXS and REGN: Codexis Inc has a market cap of $257.65M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CDXS and REGN?
CDXS (Codexis Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CDXS or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CDXS or REGN?
Both CDXS and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CDXS or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CDXS or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $257.65M for CDXS.
Should I buy CDXS or REGN in 2026?
Both CDXS and REGN have investment merit. CDXS trades at $N/A while REGN trades at $678.94. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CDXS and REGN stock?
Key differences: Market Cap ($257.65M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CDXS or REGN in 2026?
The choice between CDXS and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CDXS and REGN?
CDXS (Codexis Inc) has a market cap of $257.65M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.